U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Global Market
Related Markets
U.S. veterinary active pharmaceutical ingredients manufacturing market highlights
- The U.S. veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 3,185.4 million in 2024 and is expected to reach USD 5,279.0 million by 2033.
- The U.S. market is expected to grow at a CAGR of 5.8% from 2025 to 2033.
- In terms of segment, in house was the largest revenue generating service type in 2024.
- Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
Veterinary active pharmaceutical ingredients manufacturing market data book summary
| Market revenue in 2024 | USD 3,185.4 million |
| Market revenue in 2033 | USD 5,279.0 million |
| Growth rate | 5.8% (CAGR from 2025 to 2033) |
| Largest segment | In house |
| Fastest growing segment | Contract Outsourcing |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In House, Contract Outsourcing |
| Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.1% of the global veterinary active pharmaceutical ingredients manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 372.6 million by 2033.
The U.S. market is anticipated to grow substantially over the forecast period due to the increasing number of animal healthcare centers and practitioners. According to the American Veterinary Medical Association (AVMA) report, in 2022, around 124,069 veterinary practitioners were practicing in the country.
Further, growing concerns about pets have increased pet care expenditure, driving the veterinary medicine demand. This is expected to propel the veterinary API manufacturing market growth.
According to a report by APPA, in 2022, on average, an owner spent approximately USD 31.5 billion on supplies, live animals, and Over-the-Counter (OTC) medications. These aforementioned factors are anticipated to propel the veterinary API manufacturing market growth in the U.S.
No credit card required*
Publish Date: Nov 25, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Scope
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Menadiona | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | www.menadiona.com/ |
| SeQuent Scientific | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | sequent.in |
| Ofichem Group | View profile | 51-100 | Ter Apel, Groningen, The Netherlands, Europe | ofichem.com |
| The Chem-Pro Group | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.chemprogroup.com |
| Siflon Drugs & Pharmaceuticals | View profile | 11-50 | Hyderabad, Andhra Pradesh, India, Asia | siflonpharma.com |
| Vetpharma | View profile | 11-50 | Barcelona, Catalonia, Spain, Europe | vetpharma.com |
| Suanfarma Biotech | View profile | 251-500 | Alcobendas, Madrid, Spain, Europe | www.suanfarma.com |
| Excel Industries | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.excelind.co.in |
U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook will help companies and investors design strategic landscapes.
In House was the largest segment with a revenue share of 58.39% in 2024.
Horizon Databook has segmented the U.S. veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. market is anticipated to grow substantially over the forecast period due to the increasing number of animal healthcare centers and practitioners. According to the American Veterinary Medical Association (AVMA) report, in 2022, around 124,069 veterinary practitioners were practicing in the country.
Further, growing concerns about pets have increased pet care expenditure, driving the veterinary medicine demand. This is expected to propel the veterinary API manufacturing market growth.
According to a report by APPA, in 2022, on average, an owner spent approximately USD 31.5 billion on supplies, live animals, and Over-the-Counter (OTC) medications. These aforementioned factors are anticipated to propel the veterinary API manufacturing market growth in the U.S.
- U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Service Type Outlook (Revenue, USD Million , 2021-2033)
- In House
- Contract Outsourcing
- U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Synthesis Type Outlook (Revenue, USD Million , 2021-2033)
- Chemical Based API
- Biological API
- HPAPI
- U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Therapeutic Category Outlook (Revenue, USD Million , 2021-2033)
- Antiparasitics
- Anti-infectives
- NSAIDs
- Others
- U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Companion Animals
- Production Animals
Reasons to subscribe to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Our clientele includes a mix of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2021-2033 (US$M)
US Service Type - Veterinary Active Pharmaceutical Ingredients Manufacturing Market Statistics, 2024 - 2033 (US$M)
